According to the latest SNS Insider report, the Nucleotide Market, valued at USD 597.2 million in 2022, is set to achieve unprecedented growth, reaching USD 944.6 million by 2030. Projections indicate a robust Compound Annual Growth Rate (CAGR) of 5.9% over the forecast period from 2023 to 2030.